Suppr超能文献

奥氮平、利培酮和氟哌啶醇单次清晨口服给药对健康志愿者睡眠的影响。

Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.

作者信息

Giménez Sandra, Clos Susana, Romero Sergio, Grasa Eva, Morte Adelaida, Barbanoj Manuel J

机构信息

Centre d'Investigació del Medicament, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

出版信息

Psychopharmacology (Berl). 2007 Mar;190(4):507-16. doi: 10.1007/s00213-006-0633-7. Epub 2007 Jan 5.

Abstract

OBJECTIVES

To compare the effects of typical and atypical antipsychotic drugs on sleep activity and subjective sleep quality.

DESIGN

Randomised, double-blind, placebo-controlled, four-period cross-over, clinical trial was used to evaluate the effects of active treatments on objective and subjective sleep variables.

SETTING

Sleep laboratory evaluation.

PARTICIPANTS

Twenty healthy young volunteers, both sexes.

INTERVENTIONS

Single oral morning administrations of olanzapine 5 mg, risperidone 1 mg, haloperidol 3 mg and placebo.

MEASUREMENTS AND RESULTS

Five polysomnographic nights were evaluated: one control night and one after each intervention. Significant increase in total sleep time, sleep efficiency, slow wave sleep (SWS) and rapid eye movement (REM) sleep with decreases in wake time were observed after olanzapine. Decreases in wake time, REM sleep and stage shifts together with increases in stage 2 were obtained after risperidone. Haloperidol showed only a tendency to increase sleep efficiency and stage 2 and to decrease wake time. Olanzapine showed decreases in power density in frequencies higher than 10 Hz during all sleep stages and in frequencies lower than 5 Hz range in SWS; decreases in the dynamics of spindle frequency activity (SFA) in the second and fourth non-rapid eye movement (NREM) episodes were also obtained. Risperidone presented increases in the 3.6-10.8 Hz frequency range in NREM sleep stages and in stage 2. Haloperidol also showed increases in NREM sleep stages and in stage 2, but these were in frequencies higher than 10 Hz, with increases in the dynamics of SFA in the first NREM episode. Only a significant improvement in subjective sleep quality was observed after olanzapine.

CONCLUSIONS

Antipsychotics showed different sleep changes as their neurochemical profiles were distinct. These changes were observed even when the drug was administered 15 h before going to bed.

摘要

目的

比较典型和非典型抗精神病药物对睡眠活动和主观睡眠质量的影响。

设计

采用随机、双盲、安慰剂对照、四阶段交叉临床试验来评估活性治疗对客观和主观睡眠变量的影响。

设置

睡眠实验室评估。

参与者

20名健康的年轻志愿者,男女皆有。

干预措施

早晨单次口服5毫克奥氮平、1毫克利培酮、3毫克氟哌啶醇和安慰剂。

测量与结果

评估了五个多导睡眠图夜晚:一个对照夜晚以及每次干预后的一个夜晚。服用奥氮平后观察到总睡眠时间、睡眠效率、慢波睡眠(SWS)和快速眼动(REM)睡眠显著增加,清醒时间减少。服用利培酮后清醒时间、REM睡眠和睡眠阶段转换减少,同时第二阶段睡眠增加。氟哌啶醇仅显示出增加睡眠效率和第二阶段睡眠以及减少清醒时间的趋势。奥氮平在所有睡眠阶段高于10赫兹的频率以及SWS中低于5赫兹范围的频率的功率密度降低;在第二个和第四个非快速眼动(NREM)阶段纺锤体频率活动(SFA)的动态也降低。利培酮在NREM睡眠阶段和第二阶段3.6 - 10.8赫兹频率范围内增加。氟哌啶醇在NREM睡眠阶段和第二阶段也增加,但这些是在高于10赫兹的频率,且在第一个NREM阶段SFA动态增加。仅在服用奥氮平后观察到主观睡眠质量有显著改善。

结论

抗精神病药物因其神经化学特征不同而显示出不同的睡眠变化。即使在睡前15小时给药,这些变化也能观察到。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验